IL1B and infection: While IL-1β can induce CMV reactivation from latency in cell culture and in mouse models [31, 32], evidence also suggests that CMV employs several mechanisms to counter IL-1β activity—potentially limiting its antiviral effects to allow for more robust infection [33-36].